Epidermal growth factor receptor mutation status in cell-free DNA supernatant of bronchial washings and brushings

Accuracy of bronchial brush and wash specimens prepared by the ThinPrep method in the diagnosis of pulmonary small cell carcinoma

(2014) Cheng Wang et al.   CANCER CYTOPATHOLOGY

Performance of EGFR mutant-specific antibodies in different cytological preparations: a validation study

(2014) C. Bellevicine et al.   CYTOPATHOLOGY

Incidence of T790M mutation in (sequential) rebiopsies in EGFR-mutated NSCLC-patients

(2014) J.L. Kuiper et al.   LUNG CANCER

Malignant Pleural Effusion Supernatants Are Substitutes for Metastatic Pleural Tumor Tissues in EGFR Mutation Test in Patients with Advanced Lung Adenocarcinoma

(2014) Dan Liu et al.   PLoS One

Fixation effect of SurePath preservative fluids using epidermal growth factor receptor mutation-specific antibodies for immunocytochemistry

(2013) Akihiko Kawahara et al.   CANCER CYTOPATHOLOGY

Detection of epidermal growth factor receptor T790M mutation in plasma DNA from patients refractory to epidermal growth factor receptor tyrosine kinase inhibitor

(2013) Kazuko Sakai et al.   CANCER SCIENCE

Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors

(2013) Neal I. Lindeman et al.   JOURNAL OF MOLECULAR DIAGNOSTICS

Clinical implications of T790M mutation in patients with acquired resistance to EGFR tyrosine kinase inhibitors

(2013) Jong-Mu Sun et al.   LUNG CANCER

Detection of EGFR Mutations by TaqMan Mutation Detection Assays Powered by Competitive Allele-Specific TaqMan PCR Technology

(2013) Cristin Roma et al.   Biomed Research International

Competitive allele specific TaqMan PCR for KRAS, BRAF and EGFR mutation detection in clinical formalin fixed paraffin embedded samples

(2012) Audrey Didelot et al.   EXPERIMENTAL AND MOLECULAR PATHOLOGY

Application of a Highly Sensitive Detection System for Epidermal Growth Factor Receptor Mutations in Plasma DNA

(2012) Tomomi Nakamura et al.   Journal of Thoracic Oncology

A diagnostic algorithm using EGFR mutation-specific antibodies for rapid response EGFR-TKI treatment in patients with non-small cell lung cancer

(2012) Akihiko Kawahara et al.   LUNG CANCER

Circulating tumour markers can define patients with normal colons, benign polyps and cancers

(2011) R Mead et al.   BRITISH JOURNAL OF CANCER

Comparison of the expression levels of napsin A, thyroid transcription factor-1, and p63 in nonsmall cell lung cancer using cytocentrifuged bronchial brushings

(2011) Emiko Aikawa et al.   CANCER CYTOPATHOLOGY

Identification of non-small-cell lung cancer with activating EGFR mutations in malignant effusion and cerebrospinal fluid: Rapid and sensitive detection of exon 19 deletion E746-A750 and exon 21 L858R mutation by immunocytochemistry

(2011) Akihiko Kawahara et al.   LUNG CANCER

Detection of DNA mutations by fluorescence resonance energy transfer-based preferential homoduplex formation assay

(2010) Shiro Kitano et al.   ANALYTICAL BIOCHEMISTRY

Molecular Diagnosis of Activating EGFR Mutations in Non-Small Cell Lung Cancer Using Mutation-Specific Antibodies for Immunohistochemical Analysis

(2010) A. Kawahara et al.   CLINICAL CANCER RESEARCH

Prediction of epidermal growth factor receptor mutations in the plasma/pleural effusion to efficacy of gefitinib treatment in advanced non-small cell lung cancer

(2010) Guo Jian et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY